Logo image

Prostate cancer treatment with Lutetium 177 PSMA therapy

Prostate cancer treatment with Lutetium 177 PSMA therapy
1
Media Files
1

Overview

Type of care

Inpatient

Method

Non-surgical

About the offer

LU 177 PSMA treatment aims to kill cancer cells by beta radiation of the isotope Lutetium-177. The radioactive particle binds explicitly to prostate cancer cells regardless of their location. As a result, the drug destroys the primary tumor and distant metastases. Doctors take blood tests and examine liver and kidney functions before the procedure. But, first, a Ga68-PSMA scan is performed to detect all metastases and determine how well the particular malignant cells accumulate PSMA drug. The patient is injected intravenously for 20 minutes with the Lutetium medication. After that, he stays in a closed ward protected from radiation for two days because he is a beta radiation source. During the action of the radionuclide, he receives drugs to protect the thyroid gland and kidneys, and copious drinking, if necessary, means to reduce nausea and vomiting.  The patient can take personal belongings to the ward. They will not become radioactive. The zone of radiation does not exceed 1 millimeter. A day after the therapy, the patient is given a control examination, dosimetry, and kidney scintigraphy. Doctors achieve reduced prostate cancer metastases up to complete remission as Lu 177 treatment results. However, repeating a couple of sessions at 1-2 months intervals might be required.

What’s included

Medical service

Examination
  • clinical history-taking
  • medical records review
  • physical examination
  • consultation with a nuclear medicine specialist
Laboratory tests
  • complete blood count (CBC)
  • biochemical analysis of blood (kidney and liver function tests, electrolytes)
  • inflammation blood tests
  • urinalysis
  • PSA test
Diagnosis
  • Ga-68 PSMA PET CT scan (on the indication, price is not included)
  • renal scintigraphy with 99mTc-MAG3
Treatment
  • pre-procedure patient preparation
  • Lutetium-177 PSMA therapy
  • post-procedure care
  • control examinations
  • symptomatic treatment
Other
  • cost of radiopharmaceuticals
  • cost of essential medicines
  • cost of essential materials
  • hospitalization
  • nursing service
  • discharge medical records
  • further recommendations

AiroCare

AiroMedical support
Payment protection
Patient advocacy
Price match

Customize this offer

If you're not seeing exactly what you need here, send your custom request. You can discuss the content, specifics, price & timeline to create a personalized plan.

FAQ

What is the cost?

The total price for Prostate cancer treatment with Lutetium 177 PSMA therapy is €13,225. However, it can vary from the specifics of each case. Get in touch to get an individual estimate.

How long does the offer take?

The offer is designed for 5 days.

Does the offer require you to stay in the clinic overnight?

Where can I see the media files?

What are the age restrictions?

The offer is eligible for both adults and kids.

Can I customize the content of the offer?

Yes, the components of the deal can be changed. Get in touch with a vendor to create a personalized proposal.

Individual cost estimate. Non-binding 100% free assessment.

€13,225

Similar deals